Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BIOA stock hub

BioAge Labs, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIOAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

799.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BIOA

In the news

Latest news · BIOA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-26

P25 -105.6P50 -46.5P75 -3.1

ROIC-18

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIOA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001709941
Company name	BioAge Labs, Inc.
Country	United States
Country code	US
Cusip	09077V100
Employees	62
Employees Change	-2%
Employees Change Percent	-3.13
Enterprise value	$418.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2024-09-26
Isin	US09077V1008
Last refreshed	2026-05-10
Market cap	$799.7M
Market cap category	Small-Cap
Price	$17.99
Price currency	USD
Rev Per Employee	166,387.1x
Sector	Healthcare
Sic	2834
Symbol	BIOA
Website	https://bioagelabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.25%
EV Sales Forward	4.1x
EV/Sales	40.6x
FCF yield	-11.08%
P/B ratio	2.11x
P/S ratio	77.52x
PS Forward	7.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-63.7M
Net Income	$-89.9M
Net Income Growth Years	0%
Pretax Margin	-871.75%
Profit Per Employee	$-1.5M
ROA	-17.15
ROCE	-26.64
ROE	-25.98
ROIC	-17.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	343.56%
EPS Growth Years	2
Revenue Growth	610.96x
Revenue Growth Q	91.04x
Revenue Growth Quarters	1x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$397.7M
Cash	$383.2M
Current Assets	$391.9M
Current Liabilities	$15.8M
Debt	$4M
Debt Equity	$0.01
Equity	$379.1M
Interest Coverage	-211.5
Liabilities	$18.5M
Long Term Assets	$5.8M
Long Term Liabilities	$2.7M
Net Cash	$380.8M
Net Cash By Market Cap	$47.62
Net Cash Growth	17.27%
Net Debt Equity	$-1
Tangible Book Value	$379.1M
Tangible Book Value Per Share	$8.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	24.76
Net Working Capital	$-5.4M
Quick ratio	24.26
Working Capital	$376M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-95.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	343.1%
200-day SMA	12.21
50-day SMA	18.34
50-day SMA vs 200-day SMA	50over200
All Time High	26.62
All Time High Change	-32.42%
All Time High Date	2024-10-22
All Time Low	2.88
All Time Low Change	524.65%
All Time Low Date	2025-04-09
ATR	1.25
Beta1y	1.23
Beta2y	1.62
Ch YTD	35.98
High	18.22
High52	24
High52 Date	2026-01-15
High52ch	-25.04%
Low	17.47
Low52	3.67
Low52 Date	2025-05-15
Low52ch	390.19%
Ma50ch	-1.92%
Premarket Change Percent	-0.56
Premarket Price	$17.72
Premarket Volume	4,963
Price vs 200-day SMA	47.37%
RSI	52.12
RSI Monthly	50.61
RSI Weekly	57.56
Sharpe ratio	2.19x
Sortino ratio	4.57
Total Return	-95.07%
Tr YTD	35.98
Tr1m	2.16%
Tr1w	7.15%
Tr3m	-13.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$46
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.64
Earnings Revenue Estimate	1,083,330x
Earnings Revenue Estimate Growth	-25.34x
Operating Income	$-101.7M
Operating margin	-985.9
Price target	$51.5
Price Target Change	$186
Price Target Change Top	$156

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,026,039%
Float Percent	83.29%
Net Borrowing	-6,000,000
Shares Insiders	2.44%
Shares Institutions	56.37%
Shares Out	44,452,734
Shares Qo Q	17.41%
Shares Yo Y	95.07%
Short Float	4.71%
Short Ratio	3.27
Short Shares	3.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.6M
Average Volume	395,243.8x
Bv Per Share	8.54
CAPEX	$-319,000
Ch1m	2.16
Ch1w	7.15
Ch1y	343.1
Ch3m	-13.22
Ch6m	147.8
Change	0.95%
Change From Open	2.68
Close	17.82
Days Gap	-1.68
Depreciation Amortization	239,000
Dollar Volume	3,192,451.4
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-101.7M
EBITDA	$-101.5M
EPS	$-2.39
F Score	4
FCF	$-88.6M
FCF EV Yield	-21.16x
FCF Per Share	$-1.99
Financing CF	136,684,000
Fiscal Year End	December
Founded	2,015
Investing CF	-63,981,000
Ipr	-0.06
Iprfo	-20.04
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-24
Ma150	14.68
Ma150ch	22.52%
Ma20	17.49
Ma20ch	2.85%
Net CF	-15,709,000
Next Earnings Date	2026-08-05
Open	17.52
Optionable	Yes
Position In Range	69.33
Ppne	3,799,000
Pre Close	17.82
Price Date	2026-05-08
Ptbv Ratio	2.11
Relative Volume	0.45x
Revenue	10,316,000x
SBC By Revenue	126x
Share Based Comp	12,998,000
Tr6m	147.8%
Us State	California
Volume	177,457

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIOA pay a dividend?

Capital-return profile for this ticker.

Performance

BIOA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIOA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+56.4%

Float: +83.3% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIOA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

+47.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIOA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BIOA stock rating?

BioAge Labs, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BIOA analysis?

The full report lives at /stocks/BIOA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BIOA?

The latest report frames BIOA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BIOA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.